Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Maze Therapeutics, Inc. (MAZE) and Universal Health (UHS)
at www.tipranks.com (Mon, 22-Jun 6:46 AM)
H.C. Wainwright Sticks to Their Buy Rating for Zymeworks (ZYME)
at www.tipranks.com (Mon, 22-Jun 6:43 AM)
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) and AbCellera Biologics (ABCL)
at www.tipranks.com (Thu, 18-Jun 8:40 AM)
FDA Fast Track Designation Broadens Zymeworks’ ZW191 Potential for Ovarian Cancer—What’s Behind the Move?
Market Chameleon (Mon, 30-Mar 7:53 AM)
